𝔖 Bobbio Scriptorium
✦   LIBER   ✦

One-dose and multiple-dose kinetics of minocycline in patients with renal disease

✍ Scribed by I. Sklenar; P. Spring; L. Dettli

Publisher
SP Birkhäuser Verlag Basel
Year
1977
Tongue
English
Weight
619 KB
Volume
7
Category
Article
ISSN
1420-908X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multiple dose kinetics of ofloxacin and
Multiple dose kinetics of ofloxacin and ofloxacin metabolites in haemodialysis patients
✍ D. Kampf; K. Borner; A. Pustelnik 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 424 KB

7 patients with end-stage renal disease on regular haemodialysis were treated orally with a loading dose of 200 mg ofloxacin and multiple maintenance doses of 100 mg per 24 h for 10 days. The pharmacokinetics of ofloxacin and its metabolites were studied at the end of the treatment period. Plasma an

Mirtazapine oral single dose kinetics in
Mirtazapine oral single dose kinetics in patients with different degrees of renal failure
✍ F. Bengtsson; P. Höglund; C. Timmer; J. Hegbrant 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

To investigate pharmacokinetic parameters, as well as safety of mirtazapine in patients with renal failure, an openlabelled, single oral dose study was performed in normal healthy controls and in patients with mild, moderate and severe renal failure, as distinguished by glomerular ®ltration rates (G

Cyclophosphamide pharmacokinetics and do
Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency
✍ Haubitz, Marion; Bohnenstengel, Frank; Brunkhorst, Reinhard; Schwab, Matthias; H 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 219 KB

## Background: Intravenous pulse administration of cyclophosphamide (cyc) has been successfully used for the treatment of various autoimmune diseases. these patients often present with impaired renal function or even end-stage renal failure. nevertheless, data concerning pharmacokinetics of cyc in